Pacira Pharmaceuticals buy Royal Bank of Canada
Start price
31.07.24
/
50%
€19.10
Target price
31.07.25
€34.16
Performance (%)
0.00%
Price
31.07.24
€17.70
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada is currently unchanged from the start price. This prediction currently runs until 31.07.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | 0.00% |
iShares Core DAX® | 0.786% |
iShares Nasdaq 100 | 1.855% |
iShares Nikkei 225® | 3.947% |
iShares S&P 500 | 1.787% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Royal Bank of Canada from $42.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
01.03.24
01.03.24
€41.56
01.03.25
01.03.25
-23.66%
31.07.24
31.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
03.11.23
03.11.23
€54.04
03.11.24
03.11.24
-32.75%
31.07.24
31.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
03.10.23
03.10.23
€65.04
03.10.24
03.10.24
-27.01%
31.07.24
31.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€34.80
03.08.23
03.08.23
€62.07
03.08.24
03.08.24
-49.14%
31.07.24
31.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€40.00
01.03.23
01.03.23
€71.20
01.03.24
01.03.24
-34.50%
02.03.24
02.03.24